Inhaler container for a medical aerosol
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of an inhaler container for a medical aerosol showing my new design;
FIG. 2 is an exploded perspective view thereof;
FIG. 3 is a side elevational view thereof;
FIG. 4 is a top plan view thereof;
FIG. 5 is a bottom plan view thereof;
FIG. 6 is a perspective view thereof in storage position wherein the top is inverted and placed inside the bottom of the container position.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
D105384 | July 1937 | Lauterbach |
D134131 | October 1942 | Derham et al. |
D269463 | June 21, 1983 | Young |
2328542 | September 1943 | Bauman |
3200817 | August 1965 | Brainard |
1571859 | June 1969 | FRX |
Patent History
Patent number: D295321
Type: Grant
Filed: Sep 12, 1984
Date of Patent: Apr 19, 1988
Assignee: Glaxo Group Limited (London)
Inventor: Gerald W. Hallworth (Ware)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/650,308
Type: Grant
Filed: Sep 12, 1984
Date of Patent: Apr 19, 1988
Assignee: Glaxo Group Limited (London)
Inventor: Gerald W. Hallworth (Ware)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/650,308
Classifications
Current U.S. Class:
D24/62